as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹97.3
Change
+0.05 (0.05%)
Open
₹97.9
Prev. Close
₹97.25
Day High
₹97.9
Day Low
₹96.02
Volume Analysis
Traded
386,533
Delivered
180,499
Delivery %
46.7%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (4)
- •Trading within 3% of its 52-week low (₹95.6)
- •Low return on equity (3.75%)
- •Below-average fundamentals quality score (33/100)
- •Low operating margin (4.6%)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹100.0 | ₹98.95 | ₹98.12 | ₹97.07 | ₹96.24 | ₹95.19 | ₹94.36 |
| Fibonacci | ₹98.95 | ₹98.23 | ₹97.79 | ₹97.07 | ₹96.35 | ₹95.91 | ₹95.19 |
| Camarilla | ₹97.82 | ₹97.64 | ₹97.47 | ₹97.07 | ₹97.13 | ₹96.96 | ₹96.78 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-33.73%
1 Week
-1.47%
1 Month
-6.01%
3 Months
-27.05%
6 Months
-4.19%
1 Year
-53.8%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹41.91
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
0.08%
Net margin 0.05% × asset turnover 0.74x × equity multiplier 2.23x
Company Overview
Sector
Chemicals
Market Cap
₹1,905 Cr
P/E (TTM)
67.4
ROE
3.75%
Book Value
₹54.2
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.
TopFund Analysis
Camlin Fine Sciences Ltd scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 33/100. The strongest factor is Financial Strength (77/100), while Momentum (3/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week low (₹95.6); low return on equity (3.75%). FII holding has been falling.
TopFund Score — Fundamentals Quality
33/100 — WeakData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company's working capital requirements have reduced from 35.3 days to 22.6 days
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of 7.74% over past five years.
- −Company has a low return on equity of -6.99% over last 3 years.
- −Earnings include an other income of Rs.63.6 Cr.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Publication - Dispatch of Notice of Postal Ballot
Mr. Atul Pradhan appointed Additional Non-Executive Independent Director from September 11, 2026 for five years.
Newspaper Publication - Unaudited Financial Results for the quarter ended June 30, 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 420 | 406 | 386 | 377 | 381 | 417 | 431 | 432 | 408 | 460 | 441 | 425 | 520 |
| Expenses + | 381 | 381 | 363 | 345 | 352 | 366 | 375 | 370 | 387 | 427 | 420 | 404 | 511 |
| Operating Profit | 39 | 25 | 23 | 31 | 29 | 52 | 56 | 62 | 20 | 33 | 21 | 21 | 9 |
| OPM % | 9.0% | 6.0% | 6.0% | 8.0% | 8.0% | 12.0% | 13.0% | 14.0% | 5.0% | 7.0% | 4.7% | 5.0% | 1.8% |
| Other Income + | 6 | 2 | 2 | -96 | -15 | -151 | -8 | -22 | 0 | -4 | -24 | 103 | -10 |
| Interest | 10 | 20 | 14 | 16 | 23 | 26 | 34 | 15 | 15 | 19 | 17 | 23 | 14 |
| Depreciation | 19 | 19 | 21 | 13 | 15 | 17 | 14 | 17 | 16 | 19 | 16 | 21 | 19 |
| Profit before tax | 16 | -12 | -10 | -94 | -23 | -142 | 0 | 8 | -11 | -9 | -37 | 80 | -34 |
| Tax % | 25.0% | 72.0% | 47.0% | -13.0% | 48.0% | -18.0% | 2,164.0% | 98.0% | 0.0% | 65.0% | 0.0% | -8.0% | -1.0% |
| Net Profit + | 12 | -21 | -14 | -82 | -35 | -116 | -7 | 0 | -11 | -15 | -37 | 86 | -34 |
| EPS in Rs | 1 | -1 | -1 | -4 | -2 | -5 | 0 | 0 | -1 | -1 | -2 | 5 | -2 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 558 | 489 | 534 | 721 | 892 | 1,049 | 1,187 | 1,412 | 1,682 | 1,454 | 1,629 | 1,723 | 1,845 |
| Expenses + | 474 | 397 | 502 | 705 | 819 | 914 | 1,000 | 1,254 | 1,471 | 1,284 | 1,402 | 1,605 | 1,761 |
| Operating Profit | 84 | 92 | 32 | 16 | 73 | 135 | 187 | 158 | 211 | 170 | 227 | 118 | 84 |
| OPM % | 15.0% | 19.0% | 6.0% | 2.2% | 8.0% | 13.0% | 16.0% | 11.0% | 13.0% | 12.0% | 14.0% | 7.0% | 4.6% |
| Other Income + | 9 | -1 | 14 | 12 | 14 | 3 | 5 | 33 | -4 | -142 | -218 | 59 | 64 |
| Interest | 24 | 24 | 31 | 32 | 41 | 48 | 42 | 41 | 64 | 70 | 107 | 83 | 73 |
| Depreciation | 16 | 17 | 22 | 27 | 29 | 33 | 44 | 56 | 63 | 56 | 61 | 71 | 75 |
| Profit before tax | 53 | 50 | -6 | -31 | 17 | 58 | 105 | 94 | 80 | -99 | -159 | 23 | 0 |
| Tax % | -4.0% | 28.0% | -26.0% | -22.0% | 82.0% | 49.0% | 38.0% | 36.0% | 50.0% | 6.0% | 0.0% | -2.0% | — |
| Net Profit + | 55 | 36 | -4 | -24 | 3 | 30 | 65 | 60 | 40 | -105 | -158 | 24 | 1 |
| EPS in Rs | 5 | 3 | -1 | -2 | 0 | 2 | 4 | 3 | 3 | -5 | -7 | 1 | 0 |
| Dividend Payout % | 8.0% | 12.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 125 | 167 | 202 | 359 | 359 | 391 | 631 | 732 | 804 | 848 | 883 | 1,022 |
| Borrowings + | 160 | 180 | 331 | 373 | 461 | 539 | 550 | 646 | 801 | 683 | 652 | 720 |
| Other Liabilities + | 131 | 123 | 126 | 273 | 255 | 290 | 282 | 396 | 425 | 424 | 467 | 559 |
| Total Liabilities | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,020 | 2,320 |
| Fixed Assets + | 106 | 140 | 201 | 278 | 272 | 306 | 584 | 601 | 858 | 816 | 704 | 887 |
| CWIP | 3 | 25 | 8 | 14 | 59 | 179 | 24 | 215 | 43 | 46 | 10 | 33 |
| Investments | 1 | 1 | 19 | 115 | 11 | 7 | 7 | 7 | 8 | 8 | 61 | 30 |
| Other Assets + | 316 | 313 | 442 | 609 | 745 | 740 | 861 | 966 | 1,136 | 1,102 | 1,246 | 1,370 |
| Total Assets | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,020 | 2,320 |
| Equity Capital | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 | 19 | 19 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 46 | 72 | -9 | -15 | -9 | 86 | 117 | 145 | 51 | 139 | 23 | 82 |
| Cash from Investing Activity + | -26 | -66 | -70 | -149 | -2 | -90 | -133 | -249 | -125 | -66 | -75 | -53 |
| Cash from Financing Activity + | -15 | -7 | 91 | 182 | 26 | 3 | 39 | 136 | 60 | -86 | 76 | -25 |
| Net Cash Flow | 4 | -1 | 13 | 18 | 15 | -1 | 23 | 32 | -14 | -13 | 24 | 4 |
| CFO/OP | 68 | 91 | 5 | -33 | 10 | 77 | 82 | 111 | 34 | 110 | 27 | 90 |
| Free Cash Flow | 19 | 5 | -39 | -34 | -78 | -48 | 34 | -68 | -93 | 79 | -19 | 20 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 46.46% | 47.22% | 45.73% | 46.07% | 46.93% | 47.83% | 45.61% | 43.88% | 43.33% | 42.07% | 43.31% | 45.63% |
| Promoters | 48.03% | 48.03% | 48.04% | 48.03% | 48.03% | 48.03% | 49.09% | 49.09% | 49.08% | 48.03% | 48.03% | 48.03% |
| FII | 1.61% | 0.99% | 1.69% | 1.01% | 0.81% | 0.76% | 1.47% | 2.88% | 2.11% | 2.12% | 0.94% | 0.91% |
| DII | 3.89% | 3.75% | 4.55% | 4.88% | 4.23% | 3.38% | 3.83% | 4.14% | 5.48% | 7.77% | 7.7% | 5.42% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Camlin Fine Sciences Ltd (this stock) | 1,905 | 67.4 | 1.83 | 3.75% |
| Bharat Rasayan Ltd | 1,899 | 13.0 | 1.49 | 12.2% |
| Gocl Corporation Limited | 1,882 | 7.05 | 0.6 | 56.0% |
| Thirumalai Chemicals Ltd | 1,940 | — | 1.24 | -11.8% |
| I G Petrochemicals Ltd | 1,850 | 22.6 | 1.39 | 0.16% |
| S H Kelkar And Co. Ltd. | 1,971 | 41.7 | 1.44 | 3.71% |
| Oriental Aromatics Ltd | 1,796 | 338.0 | 2.71 | 0.5% |
Which Mutual Funds Hold Camlin Fine Sciences Ltd?
Frequently Asked Questions about Camlin Fine Sciences Ltd
Camlin Fine Sciences Ltd (CAMLINFINE) closed at ₹97.3 on NSE on 25 September 2026, up 0.05 (0.05%) from the previous close.
Camlin Fine Sciences Ltd trades on the NSE (National Stock Exchange of India) under the symbol CAMLINFINE.
Camlin Fine Sciences Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 67.4.
Camlin Fine Sciences Ltd has a dividend yield of 0.0%.
Camlin Fine Sciences Ltd's 52-week high is ₹232.0 and its 52-week low is ₹95.6.
Camlin Fine Sciences Ltd has a market capitalisation of ₹1,905 crore.
Camlin Fine Sciences Ltd has a TopFund Quality Score of 33/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Camlin Fine Sciences Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.